Related references
Note: Only part of the references are listed.The Tumor Microenvironment: Characterization, Redox Considerations, and Novel Approaches for Reactive Oxygen Species-Targeted Gene Therapy
Lucia Laura Policastro et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Investigate Pathogenic Mechanism of TXNDC5 in Rheumatoid Arthritis
Lin Wang et al.
PLOS ONE (2013)
Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis
Xiaotian Chang et al.
ARTHRITIS RESEARCH & THERAPY (2011)
ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling
Hayley K. Charlton et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Association of TXNDC5 gene polymorphisms and susceptibility to nonsegmental vitiligo in the Korean population
K-H Jeong et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
The influence of TXNDC5 gene on gastric cancer cell
Lin Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn)
Zhiqiang Li et al.
CELL RESEARCH (2009)
Clustering by neurocognition for fine mapping of the schizophrenia susceptibility loci on chromosome 6p
S. -H. Lin et al.
GENES BRAIN AND BEHAVIOR (2009)
Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: A proteomic study
Yinghong Wang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
Integrating ethics and science in the international HapMap project
MW Foster
NATURE REVIEWS GENETICS (2004)
EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor
DC Sullivan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
ERp19 and ERp46, new members of the thioredoxin family of endoplasmic reticulum proteins
B Knoblach et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)